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biological significance between HLA-DRW2 and the ability to
form anti-GBM antibodies. If so, it will be the first strong associ-
ation between the HLA complex and a disease whose immuno-
pathogenesis has been precisely defined. This finding has impor-
tant theoretical and practical implications which will be dis-
cussed.
Alternative pathway of complement defect in children with re-
current hematuria syndrome. A. Sirin, T. M. Barratt, B. A. M.
Harvey, J. F. Mowbray, and J. F. Sooth ill. Department of Im-
munology, Institute of Child Health, London, England. Recur-
rent hematuna syndrome (Berger's disease) is associated with
deposition of IgA and C3 in the kidney, presumably as antigen-
antibody complexes. Though IgA fails to activate the classic
pathway of complement, it can achieve immune elimination of
antigen, presumably by the alternative pathway. If the deposi-
tion of IgA in the kidney in these patients results from abnormal
persistence of circulating IgA complexes, this could be due to a
defect of the alternative pathway of complement. Hemolytic
complement was fixed less well by inulin and by E. coli endo-
toxin (alternative pathway activations) in the sera of 18 children
with this syndrome than it was in sera from health adults, from 10
children with genitourinary disease, and from 23 children with
miscellaneous glomerular diseases. Hemolytic complement, C3,
and immunoglobulin concentrations were normal, except that
three children had raised serum IgA, most were high in the nor-
mal range, and one was IgA-deficient. Unlike patients with an-
other defect of the alternative pathway of complement who pres-
ent with infections, allergy, and diarrhea, the sera from these
patients opsonized yeasts for polymorphonuclear phagocytosis
normally. Sera from 26 of their symptomless parents were simi-
larly defective, confirming that the defect was primary and sug-
gesting autosornal recessive inheritance. Sera from adults with
recurrent hematuria syndrome and renal IgA deposits showed
normal alternative pathway of complement activation. They
sometimes develop chronic renal failure, whereas children with
this syndrome rarely do. Our findings suggest that these two are
different diseases.
Critical role of urine acidificationin the enhanced ammoniagen.
esis of acute acidosis. R. L. Tannen and B. D. Ross. Nuffield De-
partment of Clinical Biochemistry, Radcliffe Infirmary, Oxford,
England. The metabolic response of the kidney to chronic acid-
osis includes an increase in ammonium production and in the rate
of gluconeogenesis. Acute acidosis on the other hand results in a
large increase in ammonia excretion, while in vitro preparations
of rat kidney show no increase in total ammonia production
when incubated at acid pH. In isolated rat kidney perfusions, it
has been possible to produce significant urine acidification (mean
urine pH, 5.85; range, 5.15 to 6.35, N = 23) by reducing the pH
and bicarbonate content of the perfusate from 7.4 and 23 m to
7.0 and 9.0 m, respectively. In control kidneys perfused at nor-
mal bicarbonate concentrations and physiological concentra-
tions of glutamine (0.5 mM) and glucose (5 mM), ammonia pro-
duction fell slightly with time. However, when acute acidosis
was produced after a control period of 30 to 45 mm, a significant
increase in ammonia production occurred during the subsequent
45 mm of perfusion (control, 1.35/.tmoles/min/g; acidosis, 1.71/
moles/min/g; N = 23). The increase in ammonia production in
individual perfusions was strongly correlated (r = 0.8) with the
minimum urine pH achieved. In those kidneys reaching a urine
pH of 6.0 or below, ammonium production increased from 1.26
0.10 to 1.9 0.21 (N = 12) (P <0.01). In the nonfiltering kidney
(perfused at low pressure and increased oncotic perfusion pres-
sure) acute acidosis produced only a small stimulation of am-
monia production (control, 1.01 0.O9vs. 1.23 0.14(N = 9)(P
<0.05). Increased ammoniagenesis occurs in acute acidosis and
depends upon the trapping ammonium in the urine. This in part
explains the inability to demonstrate the effect in fragmented in
vitro preparations, such as the kidney cortex slice and isolated
mitochondria.
Interaction of anti-GBM antibody and immune complexes in
rabbits. P. Trevillian and J. S. Cameron. Renal Unit, Depart-
ment of Medicine, Guy's Hospital, London, England. Anti-GBM
antibody is known to increase the glomerular uptake of carbon
particles and heat-aggregated lgG. An experiment was designed
to examine possible synergistic effects of administered anti-GBM
antibody and the presence of circulating immune complexes in
rabbits. A moderate dose of bovine serum albumin (BSA, 150
mg/kg, i.v.) did not cause overt nephritis in a control group of
New Zealand white rabbits, although in the majority of animals
there was proven immune elimination of the antigen with scanty
glomerular deposits. A small dose (3 mg/kg, iv.) of a nephrotox-
ic globulin (NTG) containing sheep antibodies to rabbit GBM did
not induce proteinuria when given to control animals. This dose
was given to three groups of test animals on day 5, day 7, or day
9 following injection of 150 mg BSA/kg, and the animals were
killed on day 15. In all animals receiving NTG on day 5, moder-
ate to severe nephritis occurred from around day 10 onwards.
Less severe, but more immediate nephritis was seen in those re-
ceiving NTG on day 9. However, only one rabbit injected with
NTG on day 7 developed a late nephritis. (One animal in this
latter group died at day 10 with severe pulmonary hemorrhage.)
All three groups showed greatly increased amounts of non-linear
immunofluorescent deposits in glomeruli when compared with
the control BSA animals. The deposits were distributed periph-
erally, adjacent to the GBM. Conclusions. 1) There is a marked
synergistic effect between two forms of immune glomerular dam-
age, that is, that mediated by anti-GBM antibody and immune
complexes. 2) Glomerular uptake of BSA complexes is increased
in the presence of anti-GBM antibody. 3)The timing of the inter-
action appears to be critical, with the most severe effects seen
when immune elimination coincides with active antibody fixation
in the glomeruli.
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Effect of levamisole on cutaneous responses to DNCB in chroni-
cally dialyzed patients. D. Bar-Sagi, Y. Maor, D. Modai. Assaf-
Harofeh Hospital, Zerifin, Israel. Twenty uremic patients or.
chronic hemodialysis were assessed with regard to the cutaneous
hypersensitivity reaction to DNCB. The same test was repeated
following three daily 150-mg doses of levamisole. Fourteen
healthy subjects served as controls. The local inflammatory re-
sponse I week after the sensitizing dose of 2,000 g of DNCB
was positive in 35% of the uremic group as compared to 100% of
the normal controls. Delayed cutaneous response to a challenge
dose of 100 sg of DNCB was positive according to accepted cri-
teria in three of the uremic group (15%), compared to 12 positive
reactions in the control group (86%). One additional uremic sub-
ject exhibited a response which was positive in extent but was
delayed by 10 days. Three more uremic patients had a response
which was both diminished and abnormally delayed. When Le-
vamisole was administered simultaneously with a repeated chal-
lenge of DNCB, three uremic patients (15%) showed reinforce-
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ment of the cutaneous response. Lymphopenia, present in 70%
of the uremic group, was manifested in two of the three uremic
patients who responded normally to DNCB. Immunoglobulin
pattern remained within normal limits in the uremic group
throughout the test period. From this study the following con-
clusions can be drawn: (I) The immediate cutaneous inflamma-
tory response to DNCB is impaired in dialyzed patients. (2) The
delayed cutaneous reaction to DNCB is deficient in most dia-
lyzed patients. (3) The cutaneous hypersensitivity response to
DNCB, may appear in dialyzed patients, up to 10 days later than
normally expected. (4) The adequacy of response to DNCB in
the dialyzed group was not related to the lymphocyte count. (5)
Immunoglobulin pattern was normal in the dialyzed group
throughout the test period. (6) Levamisole administered to the
dialyzed patients did not change appreciably their cutaneous re-
sponse to DNCB.
High-protein intake in patients on chronic hemodialysis. J.
Bernheim and M. Rathaus. Rena! Unit, Meir Hospital, Kfar-
Saba, Israel. The daily intake of proteins, calories, essential
amino acids, and histidine, calcium, sodium and potassium were
assessed in 15 patients on chronic dialysis treatment. Two
groups of patients emerged with respect to protein intake: group
A whose intake is 100 25% and group B with an intake of 152
16.4% of the recommended daily allowance. The two groups
were also different with respect to caloric, amino acids, and min-
eral intakes. Significant differences were found in the levels of
hemoglobin (8.0 1.1 g% and 9.9 0.7, P = 0.005), hematocrit
(25.0 4.0% and 30.4 3.l%,P = 0.025), and albumin (3.9
0.2 g% and 4.2 0.3%, P = 0.025). A significant correlation was
found between protein and caloric intakes and 1) hemoglobin (r
= 0.81, P = 0.005; and r = 0.58, P = 0.025),2) hematocrit (r =
0.75,P = 0.005; and r = 0.52,P = 0.05), and3) serum albumin(r
= 0.94,P = 0.005; and r = 0.82,P = 0.005). It is concluded that
high protein-caloric intake is advisable for chronically dialyzed
patients.
Regular dialysis treatment in the elderly. M. Rat haus, B. Kafri,
andJ. Bernheim. Renal Unit, Meir Hospital, Kfar-Saba, Israel.
The indication for regular dialysis treatment (RDT) in elderly pa-
tients is controversial in the literature. In our unit, nine elderly
patients are presently being treated, representing 35% of the total
unit population. Their mean age is 67.8 yr (61 to 73 yr), and the
mean duration of RDT is 16.2 months (3 to 36 months). The mean
predialysis laboratory findings (hemoglobin, albumin, urea,
creatinine, calcium, phosphorus, cholesterol, alkaline phospha-
tase, and immunoreactive PTH) are similar to those found in re-
sults of vascular surgery, fluid balance, and overall incidence of
complications. Cardiac disease is more frequent and severe in
the elderly group. Inadequate adherence to prescribed regimens
occurs more often in younger patients. The elderly patients seem
to have a decreased physical activity, but their familial relation-
ships are quite normal without the severe problem of decreased
sexual performance. Our conclusion is that advanced age is not a
contraindication of RDT.
Influence of renal function on the well-being of patients on
chronic hemodialysis. M. D. Robson, R. Lange, and M. Ravid.
Division of Nephrology and Dept. of Medicine, Sackler School
of Medicine, Jaffa Hospital, Israel. Two groups of patients, each
comprising six patients, were studied. Group A patients were
dialyzed twice weekly for a total weekly dialysis time of 12 hr
with a Travenol UIOO coil. Group B patients were dialyzed
three times a week for 18-hr weekly dialysis time. The average
creatinine clearance of group A was 2.4 cc/mm 1.4 SD. The
dialysis index was 1.3 0.46. Group B had a mean creatinine
clearance of 0.08 0.01 (dialysis index of 0.66 0.07). Points
were allocated to the two groups of patients for rehabilitation,
cardiac status, and severity of anemia. It was found that group A
patients, who were receiving much less dialysis, were much bet-
ter and completely rehabilitated, but that group B patients did far
worse. The only biochemical difference between the two groups
was the residual renal function. All the patients in group A even-
tually required dialysis three times a week during a follow-up of 2
years. In each case, symptoms of under-dialysis appeared one
month to 6 weeks following a fall in creatinine clearance. It is
concluded that residual renal function is the main factor that de-
termines the length of dialysis required.
Effect of acute administration of indomethacin on furosemide-in-
duced renin release. R. J. Viskoper and S. Dombe. Department
ofNephrology and Hypertension, Barzilai Medical Center, Ash-
kelon, Israel. Indomethacin (I), when administered for several
days, is known to modify the action of furosemide (F) on renin
release, urinary volume, urinary sodium (UaV), and potassium
excretion (UKV). A prolonged administration of I, however, is
likely to change arterial blood pressure and sodium balance,
which consequently may change renin release. The effect of I, on
F-induced renin release was examined following a single orally
administered dose of 50 mg of I, which appeared not to affect
either blood pressure or sodium balance. Eight subjects, without
renal insufficiency, were put on a salt-poor diet (60 to 70 mEq/
day) several days prior to the first investigation. Plasma renin
activity (PRA) was measured from samples taken before and four
hours after F administration (1 mg/kg of body wt, p.o.), V. UNV,
and UKV were measured during a four-hour period following the
administration of F. This investigation was repeated with I, ad-
ministered one hour prior to F. After F administration, PRA in-
creased from 1.8 0.35 to 3.7 0.95 ng/ml/hr (P = 0.005), V was
6.7 0.8 cc/mm, UNaV was 44.3 98.8 Eq/min, UKV was 127.6
17.3 1.tEq/min. I depressed the F-induced increase in PRA by
55.3%, V by 58.2%, UNaV by 49.9%, and UKV by 53.7% (P =
0.005). Conclusions. 1)1 abolishes the effect of F on PRA, V,
UNaV, and UKV, probably by its depressing effect on prostaglan-
din release. 2) F-induced renin release cannot be explained by
blocking the action of F on sodium transport into macula densa
cells as postulated before.
Role of adenylcyclase cyclic AMP in renin release. R. J. Vis-
koper and S. Kezaz. Department of Nephrology, Barzilai Medi-
cal Center, Ashkelon, and Laboratory of Clinical Research, Ha-
dassa University Hospital, Jerusalem, Israel. Rat renal cortical
adenylcyclase and phosphodiesterase activities were studied
during various stimuli of renin release: (1) 2-KGH (2-kidney
Goldblatt hypertension), (a) renal artery was clipped for 2 hours;
(b) renal artery was clipped for 2 weeks. (2) Isoproterenol in-
fusion "low" dose (0.01 ng/kglmin), (a) infusion period of 20
mm; (b) infusion period of 60 mm. Isoproterenol infusion "high"
dose (0.1 ng/kg/min), (a) infusion period of 10 mm; (b) infusion
period of 60 mm. (3) Theophylline, 7 mg/kg/mm. PRA did in-
crease in all instances, renal cortical phosphodiesterase activity
did not change. Renal cortical adenylcyclase activity increased
in experiments 18 and 28 only. Conclusion. Adenylcyclase (AC)
stimulation is not a prerequisite for renin release: AC might be
stimulated as a result of enhanced angiotensin II formation.
